Walleye Trading LLC Intra Cellular Therapies, Inc. Transaction History

Walleye Trading LLC

$46 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $87,685 - $108,103	-1,354 Reduced 50.28%	1,339 $91,000
Q1 2024 May 15, 2024	SELL	$64.37 - $75.65 $36,562 - $42,969	-568 Reduced 17.42%	2,693 $186,000
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $338,361 - $537,424	-7,297 Reduced 69.11%	3,261 $233,000
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $549,966 - $676,767	10,558 New	10,558 $549,000
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $760,455 - $989,460	17,362 Added 174.39%	27,318 $1.48 Million
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $1.14 Million - $1.41 Million	-25,978 Reduced 72.29%	9,956 $526,000
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $1.05 Million - $1.48 Million	24,695 Added 219.73%	35,934 $1.67 Million
Q2 2022 Aug 08, 2022	BUY	$43.0 - $65.64 $425,012 - $648,785	9,884 Added 729.45%	11,239 $642,000
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $344,902 - $552,787	-8,903 Reduced 86.79%	1,355 $83,000
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $166,180 - $229,406	7,120 Added 226.9%	10,258 $326,000
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $55,260 - $99,976	3,138 New	3,138 $81,000
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $96,934 - $179,953	-6,755 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $541,701 - $1.46 Million	-44,005 Reduced 86.69%	6,755 $104,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $60,504 - $320,775	8,334 Added 19.64%	50,760 $1.74 Million
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $89,438 - $120,007	8,398 Added 24.68%	42,426 $551,000
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $246,525 - $318,673	22,617 Added 198.2%	34,028 $414,000
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $118,217 - $239,174	11,411 New	11,411 $130,000
Q3 2017 Nov 14, 2017	SELL	$10.77 - $22.1 $2,154 - $4,420	-200 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	200	200 $2,000

Others Institutions Holding ITCI

# of Institutions

416

Shares Held

88.5M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.1B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account